Skip to main content
Optimization of Prodiginines as Single-Dose Curative Antimalarials.
Optimization of Tambjamines Active against Multiple Stages of Malaria Parasites.
Development of Next-Generation Antimalarial Acridones with Radical Cure Potential.
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases.
Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II.
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria.
Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series.
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
4,8-Dimethylcoumarin Inhibitors of Intestinal Anion Exchanger slc26a3 (Downregulated in Adenoma) for Anti-Absorptive Therapy of Constipation.
Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors.